Back to search

Netherlands· NL-cb64577cb5b3

Candesartan cilexetil/Hydrochloorthiazide Teva 8/12,5 mg, tabletten

A candesartan und diuretika product containing candesartancilexetil + hydrochloorthiazide, registered in Netherlands by Teva Nederland B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC C09DA06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCandesartan cilexetil/Hydrochloorthia…ATCC09DA06REGISTER NO.NL-cb64577cb5b3PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Candesartan und diuretika is registered in 12 of 19 countries.

Countries holding a registration under ATC C09DA06 (candesartan und diuretika), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose

Candesartan und diuretika · ATC C09DA06

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CANDESARTANCILEXETIL + HYDROCHLOORTHIAZIDE
Manufacturer
Teva Nederland B.V.
Country
Netherlands (NL)
ATC code
C09DA06
ATC class
Candesartan und Diuretika
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    108801

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

80 interactions on record for candesartan und diuretika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Candesartan und diuretika · interactions on record

80 records

80 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f3e5ff1c-1029-4618-a2fa-8535abe21e0d
GET /v1/drugs/f3e5ff1c-1029-4618-a2fa-8535abe21e0d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h108801_smpc.pdf",
  "strength": null,
  "atc_label": "Candesartan And Diuretics",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg108801",
  "excipients": [
    "CARMELLOSE CALCIUM (E 466)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "POLOXAMEER 188",
    "POVIDON K 30 (E 1201)"
  ],
  "substances": [
    "CANDESARTANCILEXETIL",
    "HYDROCHLOORTHIAZIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h108801.pdf",
  "authorised_at": "2013/04/04",
  "procedure_number": "DE/H/2978/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "108801",
  "additional_monitoring": "N"
}

See everything about candesartan und diuretika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.